In some brain diseases, bradykinin has also been shown to mediate BBB disruption (Gauberti et al., 2018; Marcos-Contreras et al., 2016) and modulate other factors (Gauberti et al., 2018), thus further aggravating the disease conditions. Here, KNG1 is linked to brain disorder.